Firas Al-Kaisi

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Annabel McMillan, Supratik Basu, Kamaraj Karunanithi, Elizabeth Parkins, Edward Yan Ming Lau, Gordon Cook, Christopher Parrish, Firas Al-Kaisi, Guy Pratt, Salim Shafeek, Stephen Jenkins, Danish Memon, Ceri A Bygrave, Xenofon Papanikolaou, Tara Maisel, Sandra Hassan, Shivir Moosai, Gurvin Chander, Pallav Rakesh, Bhuvan Kishore, Farheen Karim, Georgina Talbot, Farooq A Wandroo, Kwee L Yong, Rakesh Popat
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. British journal of haematology (2023)
Faouzi Djebbari, Alexandros Rampotas, Grant Vallance, Fotios P Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard L Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Toby Andrew Eyre, Ceri A Bygrave, Jaimal Kothari, Supratik Basu, Karthik Ramasamy
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients. British journal of haematology (2023)
Martin Grundy, Firas Al-Kaisi, Joanna Cull, Cathy Williams, Dean Smith, Claire H Seedhouse
A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cells. EJHaem 2 (1) (2020)

Firas Al-Kaisi.css-eqlu8i{font-size:small;padding-left:4px;}